Recent Finacing
Recent Raise
Novira Therapeutics is an antiviral drug discovery company developing oral small‑molecule capsid (core) protein inhibitors, including NVR 3‑778, to block hepatitis B virus assembly for mono‑ or combination therapy.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors